Analysts at Zacks Research raised their Q2 2025 earnings per share (EPS) estimates for Pediatrix Medical Group in a research ...

Zacks Research cut their FY2027 EPS estimates for PACCAR in a research note issued to investors on Monday, March 10th. Zacks Research analyst R. Singhi now expects that the company will post earnings ...

Wall Street expects a year-over-year decline in earnings on higher revenues when FactSet Research (FDS) reports results for the quarter ended February 2025. While this widely-known consensus outlook ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corp. (BAC), ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Thursday reported a loss of $15 million in its fourth quarter. The San Diego-based company said it had a loss of 18 cents per share.

For the year, the company reported profit of $1.2 billion, or $25.34 per share. Revenue was reported as $11.3 billion. Ulta expects full-year earnings to be $22.50 to $22.90 per share, with revenue in ...

The fund pursues its investment objectives by applying a hybrid research process, which uses both quantitative and qualitative criteria. The Advisor uses the Zacks Rank, a proprietary model ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., Eli Lilly and Co. and ...

Milestone Pharmaceuticals Inc. (MIST) on Thursday reported a loss of $12.4 million in its fourth quarter. On a per-share basis, the Montreal-based company said it had ...